Comparison of the Effects of Different COVID-19 Vaccine Platforms on the Hospitalization Rate.
- Published in:
- Vaccine Research, 2022, v. 9, n. 2, p. 42, doi. 10.61186/vacres.9.2.42
- By:
- Publication type:
- Article
Works matching IS 23832819 AND DT 2022 AND VI 9 AND IP 2
Results: 7
1
2
solation of Extracellular Vesicles of Akkermansia muciniphila as a Potential Therapeutic Platform.
- Published in:
- Vaccine Research, 2022, v. 9, n. 2, p. 27, doi. 10.61186/vacres.9.2.27
- By:
- Publication type:
- Article
3
Enhancing the Accuracy of Semi-quantitative Endotoxin Evaluation in Biopharmaceuticals and Vaccines R&D.
- Published in:
- Vaccine Research, 2022, v. 9, n. 2, p. 31, doi. 10.61186/vacres.9.2.31
- By:
- Publication type:
- Article
4
A Global Overview of Tuberculosis Vaccine Development.
- Published in:
- Vaccine Research, 2022, v. 9, n. 2, p. 47, doi. 10.61186/vacres.9.2.47
- By:
- Publication type:
- Article
5
Efficacy of Two Vaccine Platforms against SARS-CoV-2.
- Published in:
- Vaccine Research, 2022, v. 9, n. 2, p. 18, doi. 10.61186/vacres.9.2.18
- By:
- Publication type:
- Article
6
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post -COVID Era.
- Published in:
- Vaccine Research, 2022, v. 9, n. 2, p. 1, doi. 10.61186/vacres.9.2.1
- By:
- Publication type:
- Article
7
Yeast -Produced S1 Recombinant Protein of SARS-CoV-2.
- Published in:
- Vaccine Research, 2022, v. 9, n. 2, p. 37, doi. 10.61186/vacres.9.2.37
- By:
- Publication type:
- Article